- Home
- ROIV vs ZION Comparison
ROIV vs ZION Comparison
Compare ROIV & ZION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | ZION |
|---|---|---|
| Founded | 2014 | 1873 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 7.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | ZION |
|---|---|---|
| Price | $22.13 | $58.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 20 |
| Target Price | $21.94 | ★ $60.70 |
| AVG Volume (30 Days) | ★ 6.7M | 1.5M |
| Earning Date | 11-10-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | N/A | ★ 27.47 |
| EPS | N/A | ★ 5.59 |
| Revenue | $20,329,000.00 | ★ $3,207,000,000.00 |
| Revenue This Year | N/A | $12.00 |
| Revenue Next Year | $376.94 | $4.50 |
| P/E Ratio | ★ N/A | $10.55 |
| Revenue Growth | N/A | ★ 6.54 |
| 52 Week Low | $8.73 | $39.32 |
| 52 Week High | $22.45 | $59.94 |
Technical Indicators
Market Signals| Indicator | ROIV | ZION |
|---|---|---|
| Relative Strength Index (RSI) | 68.21 | 72.98 |
| Support Level | $20.14 | $52.60 |
| Resistance Level | $21.48 | $59.94 |
| Average True Range (ATR) | 0.66 | 1.28 |
| MACD | -0.02 | 0.70 |
| Stochastic Oscillator | 87.12 | 88.43 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional US bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions focuses primarily on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.